274 related articles for article (PubMed ID: 10640766)
21. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.
Ponath PD; Qin S; Ringler DJ; Clark-Lewis I; Wang J; Kassam N; Smith H; Shi X; Gonzalo JA; Newman W; Gutierrez-Ramos JC; Mackay CR
J Clin Invest; 1996 Feb; 97(3):604-12. PubMed ID: 8609214
[TBL] [Abstract][Full Text] [Related]
22. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
[TBL] [Abstract][Full Text] [Related]
23. Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
Daugherty BL; Siciliano SJ; DeMartino JA; Malkowitz L; Sirotina A; Springer MS
J Exp Med; 1996 May; 183(5):2349-54. PubMed ID: 8642344
[TBL] [Abstract][Full Text] [Related]
24. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
Lamkhioued B; Abdelilah SG; Hamid Q; Mansour N; Delespesse G; Renzi PM
J Immunol; 2003 Jan; 170(1):537-47. PubMed ID: 12496441
[TBL] [Abstract][Full Text] [Related]
25. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
Pease JE; Wang J; Ponath PD; Murphy PM
J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
[TBL] [Abstract][Full Text] [Related]
26. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.
Amerio P; Frezzolini A; Feliciani C; Verdolini R; Teofoli P; De Pità O; Puddu P
Curr Drug Targets Inflamm Allergy; 2003 Mar; 2(1):81-94. PubMed ID: 14561178
[TBL] [Abstract][Full Text] [Related]
27. Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPgammaS binding.
Wan Y; Jakway JP; Qiu H; Shah H; Garlisi CG; Tian F; Ting P; Hesk D; Egan RW; Billah MM; Umland SP
Eur J Pharmacol; 2002 Dec; 456(1-3):1-10. PubMed ID: 12450563
[TBL] [Abstract][Full Text] [Related]
28. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
[TBL] [Abstract][Full Text] [Related]
29. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
Parody TR; Stone MJ
Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
[TBL] [Abstract][Full Text] [Related]
30. IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling.
Bandeira-Melo C; Sugiyama K; Woods LJ; Phoofolo M; Center DM; Cruikshank WW; Weller PF
J Immunol; 2002 May; 168(9):4756-63. PubMed ID: 11971026
[TBL] [Abstract][Full Text] [Related]
31. Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo.
Marleau S; Griffiths-Johnson DA; Collins PD; Bakhle YS; Williams TJ; Jose PJ
J Immunol; 1996 Nov; 157(9):4141-6. PubMed ID: 8892650
[TBL] [Abstract][Full Text] [Related]
32. Eosinophil chemotaxis assay in nasal polyps by using a novel optical device EZ-TAXIScan: Role of CC-chemokine receptor 3.
Saito H; Honda K; Asaka C; Ueki S; Ishikawa K
Allergol Int; 2016 Jul; 65(3):280-5. PubMed ID: 26874579
[TBL] [Abstract][Full Text] [Related]
33. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.
Jinquan T; Quan S; Feili G; Larsen CG; Thestrup-Pedersen K
J Immunol; 1999 Apr; 162(7):4285-92. PubMed ID: 10201960
[TBL] [Abstract][Full Text] [Related]
34. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
[TBL] [Abstract][Full Text] [Related]
35. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
Sabroe I; Peck MJ; Van Keulen BJ; Jorritsma A; Simmons G; Clapham PR; Williams TJ; Pease JE
J Biol Chem; 2000 Aug; 275(34):25985-92. PubMed ID: 10854442
[TBL] [Abstract][Full Text] [Related]
36. n-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation.
Forssmann U; Hartung I; Bälder R; Fuchs B; Escher SE; Spodsberg N; Dulkys Y; Walden M; Heitland A; Braun A; Forssmann WG; Elsner J
J Immunol; 2004 Sep; 173(5):3456-66. PubMed ID: 15322211
[TBL] [Abstract][Full Text] [Related]
37. CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2.
Provost V; Larose MC; Langlois A; Rola-Pleszczynski M; Flamand N; Laviolette M
J Leukoc Biol; 2013 Aug; 94(2):213-22. PubMed ID: 23532518
[TBL] [Abstract][Full Text] [Related]
38. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils.
Dulkys Y; Schramm G; Kimmig D; Knöss S; Weyergraf A; Kapp A; Elsner J
J Invest Dermatol; 2001 Apr; 116(4):498-505. PubMed ID: 11286614
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning and functional characterization of Cynomolgus monkey (Macaca fascicularis) CC chemokine receptor, CCR3.
Iino T; Sugimoto H; Watanabe A; Encinas JA; Liu N; Floeckner J; Bacon KB
Cytokine; 2002 Sep; 19(6):276-86. PubMed ID: 12421570
[TBL] [Abstract][Full Text] [Related]
40. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
